ROGERIO RAMOS: Open Payments
NPI 1295927291 · MASON CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 27 payments from 7 companies in 2025. Trend: 2023 $436 · 2024 $527 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $180 |
| ABBVIE INC. | 6 | $110 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, UZEDY, SPRAVATO, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across IA — which companies pay providers there.
